Assenagon Asset Management S.A. Theravance Biopharma, Inc. Call Options Transaction History
Assenagon Asset Management S.A.
- $65.1 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TBPH
# of Institutions
141Shares Held
48.8MCall Options Held
0Put Options Held
11.6K-
Madison Avenue Partners, LP New York, NY9.51MShares$136 Million11.23% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$107 Million1.24% of portfolio
-
Newtyn Management, LLC New York, NY4.95MShares$70.8 Million10.56% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$54.1 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$39.5 Million4.49% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $956M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...